BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19672151)

  • 1. Proton beam therapy and the convoluted pathway to incorporating emerging technology into routine medical care in the United States.
    Steinberg ML; Konski A
    Cancer J; 2009; 15(4):333-8. PubMed ID: 19672151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology assessment, coverage decisions, and conflict: the role of guidelines.
    Sheingold SH
    Am J Manag Care; 1998 Sep; 4 Spec No():SP117-25. PubMed ID: 10185988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pros and cons. Some cite dearth of studies on effectiveness; others see therapy's unique value.
    Rhea S
    Mod Healthc; 2010 Sep; 40(39):30, 32. PubMed ID: 20929191
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrating new technology without going broke.
    Starr C
    State Health Care Am; 2002; ():29-34. PubMed ID: 12235761
    [No Abstract]   [Full Text] [Related]  

  • 8. Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy by Sean R. Tunis.
    Eddy D
    Health Aff (Millwood); 2007; 26(4):w500-15. PubMed ID: 17580317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fallacies in the arguments for new technology: the case of proton therapy.
    Hofmann B
    J Med Ethics; 2009 Nov; 35(11):684-7. PubMed ID: 19880705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton therapy holds promise, but some call for more research.
    Printz C
    Cancer; 2009 Dec; 115(23):5363-4. PubMed ID: 19927286
    [No Abstract]   [Full Text] [Related]  

  • 11. The limited regulatory potential of medical technology assessment.
    Elhauge E
    Va Law Rev; 1996 Nov; 82(8):1525-1622. PubMed ID: 16715565
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence, appropriateness, and technology assessment in cardiology: a case study of computed tomography.
    Redberg RF
    Health Aff (Millwood); 2007; 26(1):86-95. PubMed ID: 17211017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint report of the Council on Scientific Affairs and the Council on Medical Service. Technology assessment in medicine.
    Arch Intern Med; 1992 Jan; 152(1):46-50. PubMed ID: 1728928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness and evidence evaluation as criteria for coverage policy.
    Garber AM
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-284-96. PubMed ID: 15451997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges ahead for federal technology assessment.
    Neumann PJ
    Health Aff (Millwood); 2007; 26(2):w150-2. PubMed ID: 17259197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation studies in nuclear medicine: a methodological review of the literature.
    Gambhir SS; Schwimmer J
    Q J Nucl Med; 2000 Jun; 44(2):121-37. PubMed ID: 10967623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation?
    Philipson TJ; Jena AB
    AHIP Cover; 2006; 47(5):29, 31, 33. PubMed ID: 17007325
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of changing technologies in medicine.
    Schenken JR
    Arch Pathol Lab Med; 1987 Jul; 111(7):587-9. PubMed ID: 3111444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technology assessment and coverage decision making.
    McGivney WT
    AAPPO J; 1994; 4(5):11-2, 14-7. PubMed ID: 10150666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of technology on health care cost and policy development.
    Wallner PE; Konski A
    Semin Radiat Oncol; 2008 Jul; 18(3):194-200. PubMed ID: 18513629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.